Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria

Human Antibodies

Volumn 20, Issue 3-4, 2011, Pages 77-82

  Jeremiah, Zaccheaus A ^a   Idris, Halima ^b   Ajayi, Babajide B ^b   Ezimah, Anthony C U ^b   Malah, Mohammed B ^b   Baba, Maryceline M ^b  

^a NIGER DELTA UNIVERSITY   (Nigeria)

^b UNIVERSITY OF MAIDUGURI   (Nigeria)

Author keywords

blood donors; hepatitis B virus; infectious diseases; Isolated anti HBc IgM; Maiduguri

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN M;

ADULT; ANTIBODY ISOLATION; ARTICLE; BLOOD DONOR; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC DIFFERENCE; FEMALE; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; SYPHILIS; VIRUS TRANSMISSION;

ADULT; BLOOD DONORS; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN M; MALE; NIGERIA; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; SYPHILIS;

EID: 82555170647     PISSN: 10932607     EISSN: 1875869X     Source Type: Journal    
DOI: 10.3233/HAB-2011-0242     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the advisory committee on immunization practices(ACIP). Part 1. Immunization of infants, children and adolescents, Morb Mortal Wkly Rep 54(RR-16) (2005), 1-23.
2. L.C.Miller, International adoption: infectious diseases issues, Clin Infect Dis 40 (2005), 286-293. (Pubitemid 40110676)
3. J.H. Hoofnagle, Serological markers of hepatitis B virus infection, Annual Rev Med 32 (1981), 1-11.
4. R.M. Ribeiro andA.S. Perelson, Dynamics of hepatitis B virus infection, Microbes Infect 4 (2002, 829-835. (Pubitemid 35247446)
5. M. Torbenson and D.L. Thomas, Occult hepatitis B, Lancet Infect Dis 2 (2002), 479-486. (Pubitemid 34826853)
6. N.C. Almeida, E. Strauss, E.C. Sabino, M.C. Sucupion and D.A. Chamone, Significance of isolated hepatitis B core antibody in blood donors from Sao Paulo, Rev Inst Med Trop Sao Paulo 43 (2001), 203-208. (Pubitemid 33611970)
7. D.D. Douglas, H.F. Taswell, J. Rakela and D. Rabe, Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serological markers, Transfusion 33 (1993), 212-216. (Pubitemid 23073643)
8. A.D.Kitchen, T.J.Harrison, T.J.Meacock, A.J. Zukerman and J.F. Harrison, Incidence and significance of hepatitis B core antibody in a healthy blood donor population, J Med Virol 25 (1988), 69-75.
9. H.I. Joller-Jenelka, A.N. Wicki and P.J. Grob, Detection of HBs antigen in 'anti-HBc alone' positivr sera, J Hepatol 21 (1994), 269-272. (Pubitemid 24270557)
10. A.S. Lok, C.L. Lai and P.C. Wu, Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs, Hepatology 8 (1988), 766-770.
11. S.S. Bernvil, V. Andrews, M.C. Kuhns and A.L. McNamara, Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population, Transfus Sci 18 (1997), 49-53.
12. I. Cacciola, T. Pollicino, G. Squadrito, G. Cerenzia, M.E. Orlando and G. Raimondo, Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease, NEngl JMed 341 (1999), 22-26. (Pubitemid 29293716)
13. L. Piroth, C. Binquet, M. Vergne et al., The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients, J Hepatol 36 (2002), 681-686. (Pubitemid 34499406)
14. O.A. Ejele, O. Erhabor and C.A. Nwauche, Trends in the prevalence of some transfusion-transmissible infections among blood donors in Port Harcourt, Nigeria, Haema 8 (2005), 273-277. (Pubitemid 40942684)
15. M.B. Kagu, M.B. Kawuwa, A.O. Ayilara and B.Z. Ali, Seroprevalence of HIV and hepatitis viruses in directed blood donors: a preliminary report, Highland Medical Research Journal 3 (2005), 76-80.
16. F.A. Bhatti, Z.Ullah, N. Salamat,M.Ayub and E.Ghani, Antihepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implication for transfusion practice, Transfusion 47 (2007), 74-79. (Pubitemid 46006312)
17. F. Abdalla, O.W. Mwanda and F. Rana, Comparing walk-in and call-responsive donors in a national and a private hospital in Nairobi, East Afr Med J 82 (2005), 532-536.
18. M.I. Matee, E.F. Lyamuya, E.C. Mbena, P.M. Magessa, J. Sufi, G.J. Marwa et al., Prevalence of transfusion-associated viral infections and syphilis among blood donors inMuhimbili Medical Centre, Dar es Salaam, Tanzania, East Afr Med J 76 (1999), 167-171.
19. F.I. Esumeh, D. Ugbomoiko and J.O. Isibor, Seroprevalence of HIV and Hepatitis B surface antigen (HBsAg) among blood donors in central hospital, Benin City, Nigeria, J Med Lab Sci 12 (2003), 52-55.
20. F.A. Fasola, T.R. Kotila and J.O. Akinyemi, Trends in transfusion-transmissible viral infections from 2001 to 2006 in Ibadan, Nigeria, Intervirology 51 (2009), 427-431.
21. Z.A. Jeremiah and E.O. Tony-Enwin, Seroepidemiology of transfusion transmissible viral infection among University fresh students in Port Harcourt, Nigeria, Hepatitis Monthly 9 (2009), 276-281.
22. B.B. Ajayi, A.E. Moses, A.C.U. Ezimah, K.A. Adelewo, D.N. Bukbuk andM.M. Baba, HIV prevalence among blood donors in University of Maiduguri Teaching Hospital (UMTH): a ten year experience, Int J Virol 3 (2007), 35-40.